Company profile for Satellos Bioscience

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Satellos is a biotechnology company built on groundbreaking science focused on skeletal muscle regeneration. The company's overarching vision is to create and advance medicines that harness the body's natural capacity for self-repair, providing a novel approach to address severe muscle disorders. Leveraging their proprietary MyoReGenX™ discovery platform, Satellos has uncovered significant insights into the regulation of mus...
Satellos is a biotechnology company built on groundbreaking science focused on skeletal muscle regeneration. The company's overarching vision is to create and advance medicines that harness the body's natural capacity for self-repair, providing a novel approach to address severe muscle disorders. Leveraging their proprietary MyoReGenX™ discovery platform, Satellos has uncovered significant insights into the regulation of muscle cells. Their discoveries extend across a spectrum of conditions, from genetic disorders like Duchenne muscular dystrophy to age-related debilitations.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Canada
Address
Address
200 Bay Street, Suite 2800, Toronto, ON M5J 2J1
Telephone
Telephone
+1 6476601780
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmiweb.com/press-release/2025-12-09/satellos-receives-clearance-by-us-fda-and-global-regulators-to-initiate-pediatric-phase-2-study-of

PHARMIWEB
09 Dec 2025

https://www.businesswire.com/news/home/20251125463975/en/Satellos-to-Participate-in-December-Investor-Conferences

BUSINESSWIRE
25 Nov 2025

https://www.businesswire.com/news/home/20251118350676/en/Satellos-Announces-Publication-in-Nature-Communications-Supporting-its-Novel-Treatment-Approach-for-Duchenne-Muscular-Dystrophy

BUSINESSWIRE
18 Nov 2025

https://www.businesswire.com/news/home/20251030873622/en/Satellos-to-Participate-in-November-Investor-Conferences

BUSINESSWIRE
30 Oct 2025

https://www.pharmiweb.com/press-release/2025-10-21/satellos-announces-first-adult-patient-dosed-in-lt-001-an-open-label-long-term-follow-up-study-of

PHARMIWEB
21 Oct 2025

https://www.pharmiweb.com/press-release/2025-10-10/satellos-announces-new-data-further-demonstrating-safety-tolerability-and-functional-impact-of-sat

PHARMIWEB
10 Oct 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty